Citrate de Potassium 300 mg 90 Gélules
Food supplement declared in France, declaration No 2022-7-893, decision dated 14 July 2022
Citrate de Potassium 300 mg 90 Gélules (PROZIS) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Potassium. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked. Its name nevertheless states a dose above the maximum set in France in 2006: see the composition.
- Brand
- PROZIS
- Food business operator placing the product on the market
- Prozis.Com, S.A.
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 3 gélules
- Directions for use
- Prendre 3 gélules par jour.
- Intended populations
- Men, Women
- Not recommended (according to the manufacturer)
- Breastfeeding women, Pregnant women, Kidney disease
- Objectives stated by the manufacturer (these are not authorised claims)
- Nervous system
Declaration 235007, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| potassium citrate | Potassium | no limit (insufficient data) | 80 mg |
The product name states 300 mg of potassium per serving, above the maximum dose of 80 mg set by the Order of 9 May 2006, not revised since November 2006. Check the dose and number of servings on the label.
Additives
E551, E470b
Other ingredients
gélatine
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Consultez un médecin avant d'utiliser ce produit si vous êtes enceinte ou si vous allaitez. Déconseillé aux personnes âgées ou souffrant de maladies rénales. Ne pas dépasser la dose journalière recommandée. Ce produit ne doit pas remplacer une alimentation variée et équilibrée et un mode de vie sain. Maintenir hors de la portée des enfants. Conserver bien fermé dans l'emballage d'origine dans un endroit frais et sec, à l'abri de la lumière directe du soleil.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Citrate de Potassium 300 mg 90 Gélules PROZIS, declared in 2019, earlier declaration, replaced by the 2022 declaration : different composition: 1 ingredient(s) added, 1 missing
Brand : PROZIS
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Citrate de Potassium 300 mg 90 Gélules (PROZIS): composition and regulation”, https://compoatlas.com/en/supplements/products/235007-citrate-de-potassium-300-mg-90-gelules, updated 15 November 2026.